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The rejection of solid allografts is mediated primarily by sensitized lymphoid 
cells rather  than by humoral  antibodies  (1).  However,  the  cellular processes 
involved in induction of lymphocyte sensitization and in lymphocyte-mediated 
destruction  of allografted cells are not well characterized.  Although  much is 
known about the genetics of histocompatibility reactions, particularly those of 
the mouse (2), experimental systems in vivo do not provide means of studying 
these problems directly. Hence, numerous systems have been developed in an 
attempt to study allograft reactions in vitro (3). Unfortunately, most of these 
in vitro systems are limited to studying the cytotoxic effects against target cells 
of lymphocytes previously sensitized in vivo (3-8).  Such systems thus do not 
provide a way of directly studying the induction of sensitization which initiates 
the allograft reaction. 
In  order  to investigate some of  these  problems, we modified a  system of 
cellular  immunity  (9-12)  to promote the  sensitization  of mouse  spleen  cells 
against allogeneic antigens in vitro (13). Achievement of functional allosensiti- 
zation in vitro was assayed by testing the ability of the spleen cells to inhibit the 
growth  of  tumor  allografts in  vivo. The  cytolytic  effects of  sensitized  cells 
against allogeneic target fibroblasts in vitro was also tested. 
Materials and Methods 
Animals.--We employed mice of the strains C57BL/6J and C3H/ebJ or C3H/ebw. The 
latter was developed at the Experimental Animal Center of the Weizmann Institute.  These 
mice are free of the typical C3H tail lesions. In vivo studies were performed on 8-10 wk old 
mice of both sexes. We used inbred Lewis (AgB-1) or Wistar (AgB-unknown) rat strains. 
Fibroblast Cultures.--Primary monolayers of fibroblasts were derived from 16 to 17-day 
old embryos. The fibroblast cultures were prepared and maintained as previously described 
(9-12). The fibroblasts were transferred to sensitization cultures (3 X  106 fibroblasts in 60 
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mm plastic dishes [Falcon Plastics, Los Angeles, Calif.])  and target cultures (0.7  X  106 flbro- 
blasts in 35 mm plastic dishes) after X-irradiation (2000 R). Target fibroblasts were labeled 
4-5 days before use with radioactive chromium by incubation with 5ICr as Na2CrO4  (Radio- 
chemical Center, Amershaln, England) at a concentration of 2 #Ci per target plate (10-12). 
Sensitization In Vitro.--Male mice, 3 months of age, were used as donors of lymphoid cells. 
The animals were sacrificed, and spleens, lymph nodes, or thymuses were removed into sterile, 
cold phosphate-buffered saline  (PBS), 1 pH  7.2.  The cells were freed into cold PBS by ex- 
pressing the organs through a fine wire mesh using a syringe plunger. Bone marrow cells were 
collected by washing femur marrow spaces with cold PBS.  Suspensions of mouse cells were 
washed in cold PBS, centrifuged (600 g, 7 rain), counted in a hemocytometer, and resuspended 
in Dulbecco's modification of Eagle's medium (EM) with 20% fetal calf serum (FCS)  (Grand 
Island Biological Co., Berkeley, Calif.). Batches of serum were used after they were shown to 
have no detrimental effects on lymphoid cell cultures. Unless stated otherwise, 35 >(  l0  s nu- 
cleated spleen cells in 4 ml of EM +  FCS were seeded on each sensitizing fibroblast monolayer. 
In  some  studies  hydrocortisone  sodium  succinate  (Organon,  Inc.,  West  Orange,  N.J.)  or 
prednisolone sodium tetrahydrophthalate (Ciba Corp.  Summit, N.J'.),  1 #g/ml, were added 
to  the culture medium  in  order  to  promote  sensitization  (12).  Sensitization cultures were 
incubated at 37°C in 10% CO2 in moist air. After the 3rd day of culture, 3  ml of medium 
was withdrawn and replaced by fresh EM  +  FCS.  Glucocorticoids were not added  to  the 
fresh medium at this time. At the end of the 5th day the lymphoid ceils were collected from 
the sensitizing fibroblast cultures  by repeated  pipetfing of  the culture medium,  and were 
resuspended  in  cold  PBS.  The cells were  examined and counted.  Fibroblasts were  distin- 
guishable by their characteristic appearance. About 1-2  >(  l0  s nucleated spleen or lymph 
node cells were usually recovered from each sensitization culture which included glucocor- 
ticoids.  About 60-80%  of  the recovered cells appeared  to  be large blast-like cells.  In  the 
absence of added glucocorticoids, about 5-6 X  106 cells,  15-45% large, were usually recov- 
ered from each culture. Cultures of thymus cells usually yielded a much smaller number, and 
bone marrow ceils a  larger number of cells. 
Rat lymph node cells were  obtained as described previously  (9-12)  from rats weighing 
about 300 g. Rat lymphocytes were cultured with sensitizing fibroblasts in Dulbecco's modi- 
fication of Eagle's medium with 20% horse serum (HS). 
Sensitizatio~ Iu Vivo.--The 5 day sensitization schedule was duplicated in vivo by inject- 
ing mice with 1 X  l0 s strain-specific tumor cells by the intraperitoneal route and removing 
the spleens after the 5th day. Suspensions of these in vivo-sensitized spleen cells were prepared 
by expressing the spleens through a fine wire mesh into cold PBS. 
Assay of Cytolytic Effects.--Injury to target fibroblasts was measured by the 51Cr method 
developed by Berke and associates (10) with minor modifications (11, 12). Sensitized lymphoid 
cells were resuspended in EM +  FCS  (mouse) or EM +  HS  (rat), transferred in 1.5 ml to 
each of three 51Cr-labeled  target fibroblast monolayers, and cultured for 20 hr. Cell-mediated 
damage to target fibroblasts was measured as the per cent of ~lCr label released into the me- 
dium,  minus  that  measured  in  control  cultures  (usually  5-15%).  Gamma  radiation  was 
measured in a well-type sodium iodide crystal scintillation counter (Packard Instrument Co. 
Inc.,  Downers  Grove,  Ill.).  Each  experimental value represents the mean of  three  target 
cultures. 
X-Irradiatlon.--Mice  were  exposed  to  total  body  radiation  of  550  R,  using a  Picker- 
Vanguard X-ray machine  (250 kv,  15 ma). They were irradiated at a  target distance of 50 
cm (dose rate, 60 R/min) with 0.5 mm Cu and 1.0 mm A1 added filtration. 
1 Abbreviations used in this paper: EM, Eagle's medium; FCS, fetal calf serum; HS, horse 
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Tumors.--The tumors used  were fibrosarcomas  produced  by subcutaneous  injections of 
0.2 ml of 1.5% benzo(a)pyrene  in sesame oil. Sarcoma H-1 was induced in a mouse of C3H 
strain, and sarcoma SBL5 in one of C57BL strain. These tumors were strain specific andshowed 
progressive growth only in mice of their strain of origin (14). They could grow, however, insub- 
lethally irradiated allogeneic recipients  (15). Tumor T-1  was  induced  in a  mouse  of C3H 
strain and D-2 in a mouse of C57BL strain. These tumors were used in their second to fourth 
transfer generation and were also found to be strain specific. Suspensions of tumor cells were 
obtained by trypsinization of excised tumor tissue. 
Inhibition of Tumor C-rowth.--In preliminary experiments it was found that a dose of 1 X 
106 sarcoma cells produced palpable tumors in allogeneic recipients when the mice were in- 
jected within 24 hr after irradiation. In addition, this dose of sarcoma cells was not great 
enough to obscure the inhibitory  effect of sensitized lymphoid cells. Thus, in the in vivo system, 
1 X  106 sarcoma cells in 0.1 ml of PBS were mixed with 0.1 ml of PBS with or without lymph- 
oid cells. The cell mixture was injected by intramuscular route into the right thigh of irradi- 
ated recipient mice. The mice were examined for palpable tumors at intervals, for periods of 
up to 30-40 days. 
RESULTS 
Inhibition of Tumor Allografts  by Spleen Cells Sensitized In Vitro.--The first 
series of experiments was aimed at testing whether mouse spleen cells sensitized 
in vitro will inhibit the growth of tumor allografts. 
Table  I  shows  the  cumulative  results  of  seven  experiments  in  which  the 
growth  of  aUogeneic tumor  cells was  tested  after  injection of  tumor  cells to- 
gether with mouse spleen cells allosensitized in vitro. Control mice were injected 
with tumor cells alone, or with a mixture of tumor cells and unsensitized mouse 
spleen  cells or  spleen  cells sensitized in vitro  against  rat  fibroblasts. It  was 
found that only 4%  (5~24)  of mice injected with tumor cells together with an 
equal number  of specifically allosensitized spleen cells developed tumors.  The 
allogeneic tumors were  ultimately rejected in most  experiments after  the  re- 
cipient  mice  apparently  recovered  from  the  immunosuppressive  effects  of 
irradiation (Fig. 1). However, the high degree of sensitization induced in vitro 
was  demonstrated by the  ability of  allosensitized spleen cells to inhibit even 
tumors which were potentially lethal. Fig. 2 shows the time course of experiment 
1  (Table I). In this experiment, in contrast to the others,  all six control mice 
died as a result of massive tumor  growth.  Five of  the six mice  died within  18 
days and one died 40 days after injection of sarcoma cells. Nevertheless, tumor 
growth was completely inhibited in 9,  and only a  transient tumor appeared in 
1, of the 10 mice in the experimental group. 
Inhibition of Tumor Allografls  by Spleen Cells Sensitized ln Vivo.--The above 
findings prompted us to compare the efficiency of this tumor inhibition to that 
produced by spleen cells sensitized in vivo. Table II demonstrates the effects 
of injecting irradiated recipient mice with  1  X  106 D-2,  C57BL  strain tumor 
cells, together with various numbers of unsensitized spleen cells, or spleen cells 
derived from mice allosensitized in vivo or in vitro. It can be seen that  1  X  106 
spleen cells allosensitized in vivo did not prevent the growth of 1  X  106  allo- 824  ALLOGRAFT  REJECTION  BY  IN  VITRO-SENSITIZED  CELLS 
geneic tumor  cells.  However,  increasing the  number of  these  spleen cells  to 
5  X  106  (group 3)  or  10  ~ (group 4)  was  associated with  inhibition of  tumor 
growth, similar to that produced by 1 X  106 spleen cells allosensitized in vitro 
TABLE  I 
Inhibition of Tumor Allografts by Spleen Ceils Sensitized In Vitro* 
X-irra- 
Exp.No. [ r ed~i;tied  t 
mice 
2  C57BL 
3  E57BL 
4  C3H 
I 
5  IC57BL 
6  C3H 
7  IC57BL 
Control spleen cells 
Tumors 
(strain of origin) 
Type 
H-1 (C3H)  None 
H-1 (C3H)  C57BL anti- 
Lewis rat 
H-1 (C3H)  C57BL anti- 
Wistar rat 
SBL-5 (C57BL)  Unsensitized 
C3H 
Unsensitized 
C57BL 
T-1 (C3H)  C57BL anti- 
Lewis rat 
None 
D-2(C57BL)  None 
H-1 (C3H)  C3H anti- 
C57BL 
Total incidence of palpable tumors 
Per cent 
P  <  0.0Ol 
Inci- 
dence of 
palpable 
tumors 
6/6 
6/10 
7/s 
6/8 
5/8 
7/10 
5/8 
28/28 
12/12 
82/98 
83 
Allosensitized spleen cells 
C57BL anti-C3H 
C57BL anti-C3H 
C57BL anti-C3H 
C3H anti-C57BL 
Inci- 
Type  dence of 
palpable 
tumors 
1/lO 
o/15 
0/23 
2/11 
0/8 
0/10 
0/35 
2/12 
5/124 
4 
C57BL anti-C3H 
C57BL~ anti-C3H 
C3H anti-C57BL 
C57BL anti-C3H 
* 35 X  106 nucleated spleen cells were sensitized in tissue culture  against fibroblasts in 
the  presence of  1 /~g/ml of hydrocortisone. In experiment 5,  the  spleen cells marked  (:~) 
were sensitized without added hydrocortisone, l  >( 106 tumor cells alone or mixed with 1 X 
106 spleen cells were injected into X-irradiated  recipient mice. 
(Tables I  and II). Unsensitized control spleen cells did not prevent the develop- 
ment of tumor even at doses of 107 cells (group 5). These findings suggest that 
populations of spleen cells sensitized in vitro may be several times more active 
than populations of spleen cells obtained after sensitization in vivo. 
Cylolytic Effects of Rat and Mouse Lymphoid Cells In Vitro.--Ithasbeenshown 
that lymph node cells of rats can be both sensitized against, and cause injury to IRUN  R.  COHEN,  AMIELA  GLOBERSON,  MICHAEL  FELDMAN  825  8o! 
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Fro. 1.  Inhibition of C3H tumors by C57BL spleen cells sensitized in vitro. C57BL spleen 
cells  were sensitized  against  fibroblasts of a  Lewis rat  or C3H  mouse with  (O----O),  or 
~ithout 1/zg/ml of hydrocortisone (A  A), and were injected into recipient mice together 
with tumor cells  (Table I, exp. 5). 
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Fro. 2.  Prevention of lethal takes of C3H tumors by C57]BL spleen cells sensitized against 
C3H fibroblasts in vitro ('Fable  I, exp.  1). 
allogeneic  rat  (11-13)  or mouse  (9-11)  fibroblasts  in vitro.  We,  therefore,  at- 
tempted  to  assay  the  cytolytic  capacity  of  allosensitized  mouse  lymphocytes 
against  allogeneic target fibroblasts  in vitro. Table III  shows  the results  of an 
experiment  in  which  lymph  node  cells  were  obtained  from  Lewis  rats  and 826  ALLOGRAFT  REJECTION  BY  IN  VITRO-SENSITIZED  CELLS 
C57BL mice, and 20  X  106 were sensitized against C3H mouse or Wistar rat 
fibroblasts in vitro. It was found that 3  X  106  allo- or xenosensitized Lewis 
TABLE  II 
Effect  on Allograft  Tumor Growth Produced  by Spleen  Cells Sensitized  In  Vitro,  as Compared 
with Cells of Immunized Mice or with UntreateJ Spleen  Cells* 
Group 
No. 
lit 
2 
3 
4 
Strain origin of 
Spleens  Sensitizing 
tested  ceils 
C3H  C57BL 
C57BL  C57BL 
C3H  C57BL 
C3H  C57BL 
C3H 
C57BL  -- 
Sensitization  route 
Tumor growth :~ 
[ 2M107  107  5  X  10~(  106  I 
In vitro  N.T.  ! N.T.  N.T.  0/35  28/28 
In vitro  N.T. !N.T.N.T.  35/351 
In vivo, i.p. injec-  0/10  0/10  0/10  4/9 
tion of cells  ! 0/9  0/10  3/10  4/10  In vivo, s.c. injec- 
tion of cells 
--  1/9  6/10  8/9  10/10 
--  9/9  110/I0  10/I0  10/10 
Experimental 
Control § 
14/16 
19/19 
N.T., not tested. 
* D-2 fibrosarcoma of C57BL/6 origin was tested in C3H/ebw irradiated mice. 
Mice were inoculated with a mixture of 106 tumor cells with different doses of test cells. 
§ Mice were inoculated with 106 tumor ceils only. 
II Included in Table I, exp. 6. 
TABLE  III 
Cytolytie  Effects  of Rat and  Mouse  Lymph Node  Cells Sensitized  In  Vitro 
Sensitization  phase  Cytolyfic  effector phase* 
aCr released from target fibroblasts 
Lymph node cells  Sensitizing fibroblasts 
(20 X  10Q  C3H  Wistar 
(%)  (%) 
Lewis rat  Wistar rat  7  32 
Lewis rat  C3H mouse  38  5 
C57BL mouse  C3H mouse  0  0 
* 3 X  l0  G  sensitized lymph node cells per target culture. 
lymphocytes produced  immunospecific release  of  aCr  from  the  target  cells 
against which they had been sensitized. In contrast, the C57BL mouse lympho- 
cytes were  unable to  cause either specifc  or nonspecific release of  5'Cr from 
target cells. 
Resistance of  C3H target fibroblasts to lysis could not explain the apparent IRUN  R.  COHEN,  AMIELA  GLOBERSON,  MICHAEL  FELDMAN  827 
failure  of mouse  lymph node cells  to produce  cytolytic release  of  51Cr, since 
these  target  fibroblasts  were  susceptible  to injury by sensitized  rat  lympho- 
cytes.  It  was  possible,  however,  that  the  mouse  lymph  node  cells  were  not 
adequately  sensitized.  We  therefore  sensitized  C57BL  spleen  cells  against 
C3H or Lewis rat fibroblasts,  with  or without the presence of hydrocortisone 
in the sensitizing cultures. Table IV shows the results of assaying these cells for 
cytolytic effects against specific target fibroblasts in vitro, and for inhibition of 
growth of C3H tumor cells in vivo. As demonstrated  in the experiments  cited 
TABLE IV 
Effects o] Sensitized C57BL  Mouse Spleen  Cells  on  Target Fibroblasts  In  Vitro  and  on  the 
C~owth of Tumor Allografts in Vivo 
Sensitization phase in vitro* 
Sensitizing  Hydrocortisone 
fibroblasts 
Effector phase 
In vitro:~  In vivo§ 
SlCr released from target fibroblasts  Incidence  of palpable 
C3H tumors (T-l) 
(%)  (%) 
C3H  Lewis 
C3H  +  4  N.T.  0/10 
--  0  N.T.  0/7 
Lewis rat  +  N.T.  0  N.T. 
--  N.T.  0  7/10 
None  --  0  0  5/8 
N.T., not tested. 
* 45 X  l0  s nucleated spleen ce]ls were obtained from C57BL mice and sensitized against 
C3H mouse or Lewis rat fibroblasts with or without 1/zg/ml of hydrocortisone in the culture 
medium. 
.* 3.5 X  106 sensitized spleen cells per target culture. 
§ Included in Table I, exp. 5. 
above, the allosensitized C57BL spleen cells completely inhibited the growth of 
C3H  tumors  in vivo.  This  indicates  that functional  allosensitization  was  in- 
duced.  Nevertheless,  the  sensitized  mouse  spleen  cells  had  no  demonstrable 
cytolytic effects  on  either  C3H  mouse  or Lewis  rat  target  fibroblasts  in  cell 
culture. 
These findings  suggested  that  cytotoxic effector cells  may have been  defi- 
cient in sensitization  cultures  derived from mouse spleens  as well  as in those 
derived  from lymph  nodes.  A  recent  analysis  of  the  cytolytic effects  of rat 
lymphoid cells against target fibroblasts (16) indicated that the reaction is based 
upon cooperation between  two  types  of lymphocytes,  one of thymus  and  the 
other of nonthymus origin. We therefore carried out six experiments  in which 
cells for in vitro sensitization were obtained from thymus or bone marrow,  as 828  ALLOGRAFT REJECTION  BY  IN  VITRO-SENSITIZED CELLS 
well  as  from  spleen  or  lymph  nodes.  However,  allosensitization  of  mouse 
lymphoid cells derived from any of these sources, alone or in various combina- 
tions,  did  not lead  to cells  capable of causing significant lysis of target  fibro- 
blasts in vitro. Table V  shows the results of one of these studies. 
Inhibition  of Lymphocyte  Se~sitization  by  Anti-Fibroblast  Anlibodies.--The 
immunospecificity of the  induction of sensitization  of rat  lymphocytes against 
mouse fibroblast antigens was studied previously (17). It was found that sensi- 
tization of lymphocytes in vitro could be inhibited by preincubating  the sensi- 
tizing fibroblasts with rat  anti-mouse antiserum.  The magnitude of inhibition 
TABLE V 
In  Vitro Cytolytic l~ffect of C57BL  Mouse  Lymphoi~  Cells Sensitized In  Vitro agai~st C3tt 
Fibroblasts 
Sensitization  phase*  Cytolytlc effector phase~ 
~lCr released  from target fibroblasts 
Type of lymphoid  cells 
C3H  Lewis 
(%)  (%) 
Spleen  1  3 
Bone marrow  4  3 
Lymph node  4  2 
Thymus  1  4 
Bone marrow +  thymus -t- spleen  4  3 
* 30 X  106 C57BL lymphoid cells, or mixtures of 10 X  106 of each of three  types, were 
sensitized in vitro against C3H fibroblasts. 
4 X  106 cells per target culture. 
of sensitization appeared to correlate with the concentration of antibodies bind- 
ing to the sensitizing fibroblasts.  It was concluded, therefore,  that an immuno- 
specific  interaction  between  rat  lymphocytes  and  mouse  fibroblast  antigens 
was necessary for the induction of lymphocyte sensitization. Hence, it would be 
expected  that  preincubation  of sensitizing  mouse fibroblasts  with  antisera  to 
alloantigens  also would  inhibit  the  in vitro  sensitization  of allogeneic mouse 
spleen  cells.  To test  this,  C3H  sensitizing  fibroblasts  were preincubated  with 
C57BL  anti-C3H  antiserum  or with  normal  serum.  C57BL  spleen  cells  were 
then added to the sensitizing cultures.  C3H tumor cells were mixed with these 
sensitized spleen cells or with serum alone and injected into recipient irradiated 
C57BL mice. The results are shown in Table VI. It was found that 30%  (3/{0) 
of  the  mice  receiving  tumor  cells  in  normal  serum  developed  tumors.  C3H 
tumor  cells  injected  together  with  C57BL  anti-C3H  antiserum  produced 
tumors in 78%  (7/~) of the mice. The augmented growth of these C3H tumors 
suggests that rejection of tumors was not mediated by interaction with extra- 
cellular antibodies.  Tumors did not develop (0/8)  in mice which received tumor IRUN  R.  COHEN,  AMIELA  GLOBERSON,  MICHAEL  •ELDMAN  829 
cells together with C57BL spleen cells which were cultured with C3H fibroblasts 
in the presence of normal serum. This result  is in accord with  the low overall 
incidence  of tumors  (4%)  in mice receiving  allosensitized  spleen  cells,  which 
was presented  in Table I. This indicates  that allosensitization  was induced in 
the presence  of normal serum.  On the  other  hand,  tumors  developed  in 25 % 
(3~2)  of mice which were injected with C57BL spleen cells that had been cul- 
tured with C3H fibroblasts in the presence of the anti-C3H  antiserum  (Table 
VI).  Although the  numbers  of mice used in  this  experiment  were small,  it  is 
noteworthy  that  this  incidence  of tumors  (25 %)  was  about  the  same  as  the 
TABLE VI 
Effects  of Antibodies  on Sensitization  of C57BL Spleen  Cells and  Growth of Tumors 
C3I-I tumor cells injected together with  Incidence of tumors in 
irradiated C57BL mice 
C57BL serum  Spleen cells*  Number  Per cent 
Normal serum 
Anti-C3H antiserum:~ 
--  3/10  30 
--  7/9  78 
Sensitized against C3H 
in the presence of:§ 
Normal serum  0/8  0 
Anti-C3H serum  3/12  25 
* 1 X  106 T-1 tumor cells were mixed with 0.1 ml of serum or with 1 X  106 C57BL spleen 
cells. 
C57BL mice were injected intraperitoneally  weekly for 8 wk with 5 X  107 C3H spleen 
cells. Sera were collected 1 wk later. 
§ Sensitizing C3H  fibroblasts  were  preincubated  with  0.4  ml  of normal  or  anti-C3H 
antisera  diluted  1:2 in EM for 40 rain. The sera were removed by aspiration  before spleen 
cells were added for sensitization. 
incidence  of tumors  in  control mice injected  with  normal  serum  (30%).  The 
failure of these spleen cells to inhibit tumor growth indicates that lymphocyte 
sensitization  was  abolished  in  the  presence  of  antibodies  to  allogeneic fibro- 
blast antigens. 
DISCUSSION 
This  paper  reports  the  induction  of primary  sensitization  of mouse  spleen 
cells  against  allogeneic  fibroblasts  in  vitro.  Achievement  of functional  allo- 
sensitization  was  indicated  by the  ability  of these  spleen  cells  to inhibit  the 
growth of tumor allografts in vivo. Allo-antibodies binding to antigens of sensi- 
tizing fibroblasts appeared to block the allosensitization of spleen cells in vitro. 
This indicates, as suggested in earlier studies (17), that an immunospecific inter- 
action between spleen cells and sensitizing fibroblasts is necessary to initiate the 
induction of sensitization.  Injecting tumor cells together with preformed allo- 830  ALLOGRAFT  REJECTION  BY  IN  VITRO-SENSITIZED  CELLS 
antibodies alone led to enhancement of tumor growth rather than to rejection. 
This suggests that inhibition of tumor growth in the presence of allosensitized 
spleen cells was not brought about by extracellular antibodies. Hence, the in 
vitro system appears to behave as a model in which cell-mediated allosensitiza- 
tion can be studied. 
Hellstr6m  and  Hellstr6m  (18)  recently summarized  the  literature  dealing 
with  the "neutralization" of tumor allografts by lymphoid cells  sensitized in 
vivo against  transplantation  antigens.  They indicated that  a  ratio of 10:200 
lymphoid cells  per  tumor cell is  usually necessary in  order to detect growth 
inhibition in X-irradiated recipient mice. We found that about 5 X  106 in vivo- 
sensitized spleen cells were needed to inhibit 1 X  106 tumor cells in irradiated 
recipients. In contrast to this cell ratio of 5:1, the spleen cells sensitized in cell 
culture were able to inhibit the growth of an equal number of tumor cells.  It 
was found in a previous study (12) that sensitization in cell culture can promote 
the selection of specifically sensitized lymphocytes. Thus, the relative number 
of specifically active cells in a population of spleen cells after sensitization in 
vitro may be greater than that obtained after sensitization in vivo. Neverthe- 
less,  these highly sensitized populations of mouse spleen cells were not able to 
injure target fibroblasts in vitro. 
The failure of the in vitro-sensitized mouse spleen cells to produce cytotoxic 
effects against target cells in vitro might be explained by a possible defect in 
their ability to recognize fibroblast antigens.  This is unlikely, however, since 
sensitization  was  found  to  depend  upon  recognition of allo-antigens  on  the 
sensitizing fibroblasts in vitro. Recognition in vivo was  demonstrated by  the 
inhibition of tumor growth. Thus, the lack of in vitro cytotoxicity of these cells 
cannot be explained by a failure to recognize allo-antigens.  This finding sug- 
gests,  therefore, that recognition of antigen and cytotoxic effect are  two dis- 
tinguishable processes of sensitized lymphocytes. 
We have recently analyzed the cytolytic effects of rat lymphocytes against 
target fibroblasts in vitro (11, 17). These studies provided more direct evidence 
that the effector response of sensitized lymphocytes can  be  divided into  two 
major stages. The first stage appears to be activation of the cytolytic potential 
of sensitized lymphocytes. This appears to be brought about by immunospecific 
contact between lymphocytes and antigens. The second stage is the mediation 
of injury to the target cells. This stage does not seem to be immunospecific and 
antigen-activated lymphocytes were found to injure antigenically nonspecific 
fibroblasts, provided that close contact could be made (11, 17). 
It is possible, therefore, that mouse spleen cells which have been sensitized 
in vitro lack the effector mechanism demonstrated in rat cells which is needed to 
injure target cells.  This cytolytic mechanism may be activated by further dif- 
ferentiation of sensitized mouse lymphocytes in vivo. Alternatively, it may be 
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sensitized  lymphocytes  and  "nonspecific" effector  cells  recruited  from  the 
recipient mice. Ax and associates  (19)  independently have  developed  an  in 
vitro method for allosensitization of mouse lymphoid cells which is similar to 
ours. They report that these lymphoid cells are able to lyse allogeneic masto- 
cytoma target  cells  which are  highly susceptible  to  lysis (6).  However,  the 
failure of sensitized mouse cells to produce the cytolytic effects demonstrated by 
rat cells against the same target fibroblasts remains unexplained. 
There is no direct evidence, on the other hand, that the process of cytolysis 
measured in vitro plays any role in the rejection of allografts in vivo. Thus, 
there  might be  no  necessary functional relationship  between  the  ability of 
lymphocytes to reject allografted cells or tissues and their ability to lyse target 
cells in cell culture. Sensitization is certainly not a prerequisite for lymphocyte- 
mediated injury to target cells. It has been shown that nonsensitized lympho- 
cytes may be activated by a variety of nonimmune substances such as phyto- 
hemagglutinin to produce lysis of target cells (3, 20). 
Attempts have been made to characterize  lymphocyte recognition of allo- 
antigens by studying cytotoxicity to target cells produced by sensitized lympho- 
cytes (3).  Brondz (8)  has suggested that an immune lymphocyte can interact 
with a  target cell only if there exists a  suitably close fit between target allo- 
antigens and a whole complex set of lymphocyte receptors. Mauel and associates 
(7) also interpreted their fndings as suggesting a  similar possibility. However, 
the results described here indicate that the conditions necessary for the expres- 
sion of lymphocyte-mediated cytotoxicity may not be directly related to the 
process  of  antigen  recognition  itself.  Hence,  caution  must  be  exercised  in 
extrapolating the results of cytotoxic experiments to analyze the problem of 
lymphocyte recognition of antigen. 
The in vitro system of allosensitization, on the other hand, provides a means 
of studying sensitization of lymphocytes which is triggered by recognition of 
antigens. In addition to inhibiting tumor allografts, spleen cells sensitized in 
vitro have been found to produce graft vs. host reactions in newborn animals 
(13). This model of cellular immunity, therefore, appears to be unique in that 
it is initiated in vitro but still is measurable in vivo. 
We have found in recent studies that in vitro-sensitized spleen cells injected 
intraperitoneally reject allogeneic fibrosarcoma cells grafted separately into the 
thigh muscles or footpads of recipient mice. About 15  X  106 in vitro-allosen- 
sitized spleen cells were able to transfer specific  resistance to 1 X  106 tumor 
cells. Similar numbers of nonsensitized spleen cells or spleen cells allosensitized 
in vivo, injected intraperitoneally, were unable to reject the tumor cells. These 
findings indicate that in vitro-allosensitized spleen cells need not be mixed with 
tumor cells locally to inhibit their growth in vivo. The ability of spleen cells to 
function systemically provides additional evidence of their state of allosensi- 
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SUMMARY 
This paper reports a model system of cellular immunity in which allosensiti- 
zation of mouse spleen cells is induced in vitro. Allosensitization was achieved 
by culturing spleen cells upon monolayers of allogeneic fibroblasts. The ability 
of the spleen cells to inhibit the growth of tunIor allografts in vivo served as a 
functional  assay of  sensitization.  We found  that  unsensitized  spleen  cells  or 
spleen cells sensitized against unrelated fibroblast antigens had  no  inhibitory 
effect on the growth of allogeneic fibrosarcoma cells when they were injected 
together into irradiated recipients. In contrast, spleen cells which were specifi- 
cally allosensitized in vitro were found to be highly effective in inhibiting the 
growth of an equal number of allogeneic tumor cells.  Several times more spleen 
cells from mice sensitized in vivo were required to produce a  similar immune 
effect. This confirms the findings of previous studies which indicate that sensi- 
tization  in  cell  culture  can  promote  the  selection  of  specifically  sensitized 
lymphocytes. 
Preincubating  sensitizing  fibroblasts  with  allo-antisera  blocked  the  allo- 
sensitization of spleen cells. This suggests that antibodies binding to fibroblasts 
may inhibit the induction  of sensitization by competing with lymphocytes for 
antigenic sites. 
Mouse spleen cells which were able to recognize and reject tumor allografts 
in vivo were unable to cause lysis of target fibroblasts in vitro. Such fibroblasts, 
however, were susceptible to lysis by rat lymphoid cells sensitized by a similar 
in  vitro  method.  These  findings  indicate  that  the  conditions  required  for 
lymphocyte-mediated lysis of target cells may not  be directly related  to the 
processes of antigen recognition and allograft rejection in vivo. 
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